Clinical Trial Update: A Study of LY2216684 and Warfarin in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed the interaction between Eli Lilly's LY2216684 and Warfarin in healthy subjects. The study lists Major Depressive Disorder as the condit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• LY2216684
• Warfarin (warfarin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED | Results posted: 2018-10-19